Ticker ADMP – Adamis Pharmaceuticals Corporation – sales, description, marketcap – Tickerday.com

ADMP

Adamis Pharmaceuticals Corporation

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 73.39M; Volume: 808.82K; AvgVol 3m: 6.52M; Beta: –;

Cost estimate:

P/E: –; EPS: -0.52; EPS growth quarter/prev quarter: 6.20%;

EPS growth this year: 44.90%; EPS growth past 5 years: 9.10%;

EPS ttm: -0.52;

P/S: 3.65; P/B: 2.48; P/Cashflow: 9.24; P/FCF: ;

Sales: 20.03M; Sales growth quarter/prev quarter: -32.80%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 17.30%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -73.70%; ROE – return on equity: -103.20%; LT Debt/Equity: 0.09; Total Debt/Equity: 0.23;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.40%; Insider Transactions:-8.17%;

Institutional Ownership: 5.70%; Institutional Transactions: -54.45%;

Data update: 07.10.2020.